Non-small cell lung cancer: Biomarkers, treatments, and outcomes in real-world data
Johns Hopkins builds research community to explore new frontiers in health using Truveta Data
Inside The Race To Harness Real-World Data: Who Will Build Healthcare’s Most Powerful Platform?
Impact of the CVS GLP-1 formulary change: Trends in switching
Impact of the CVS GLP-1 formulary change: Trends in prescribing
One-year cardiovascular outcomes after GLP-1 discontinuation
Truveta experts: Biomarker testing trends in metastatic non-small cell lung cancer (NSCLC)
Multiple sclerosis: Real-world treatment patterns and outcomes
